measurement in several countries resulting a significant decrease across economic activities which expected a deep economic deceleration throughout the year. During the last period shrinking economy impacted
medical treatments went down 0.86 % due to the expenses of CMR increased 0.37% and the separate financial decrease 2.53%. 3. The net income increased 70.30% (Separate financial statement : increased 13.61
treatments went down 9.20 % due to the expenses of CMR decreased 2.34% and the separate financial decrease 2.45%. 3. The net income increased 27.08% (Separate financial statement : increased 20.11 %) due to
income from medical treatments went down 1.62 % due to the expenses of CMR decreased 1.46% and the separate financial decrease 1.52% . 3. The net income increased 79.98% (Separate financial statement
% and the separate financial decrease 1.52% . 3. The net income increased 79.98% (Separate financial statement : decreased 23.16 %) due to the share of profit of associates increased amount Baht 55.49
revenue of 732.18 million baht, a decrease of 132.84 million baht compared to the same period of year 2018, which has sales revenue of 865.01 million baht or 15.36 % decrease as a result of the product
performance of the Group Unit: Million Baht 2019 2018 Increase (decrease) Variance (%) Total revenues 6,797 8,080 (1,283) (16%) Net profit 331 526 (195) (37%) The Group’s total revenues for 2019 amounted Baht
performance of the Group Unit: Million Baht Q1’ 2019 Q1’ 2018 Increase (decrease) Variance (%) Total revenues 1,677 1,978 (301) (15%) Net profit 81 116 (35) (30%) The Group’s total revenues for the first
the company achieved expansion loans target while the domestic economic recovery. The total income was 963.01 million baht, an increase of 123.30 million baht or 14.68%. Interest expenses were 219.50